PlainRecalls

X-Gen Pharmaceuticals Inc.

Compiled from official public sources by the publisher.

8 recalls on record · Latest: Apr 10, 2024

Subscribe to new X-Gen Pharmaceuticals Inc. recalls (RSS)

Agency notice ledger

Federal filing book X-Gen Pharmaceuticals Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,853 of 14,151 · 8 notices · 0.008% archive

  • BOOK 8 notices
  • RANK #1,853 of 14,151
  • SHARE 0.008% archive
  • AGENCY FDA Drug (8)
  • CAT drugs
  • CATS 2 categories
  • LATEST Apr 10, 2024
  • PHOTO Ab Sciex

Nearest notice-volume peer: Ab Sciex (0 notice gap)

X-Gen Pharmaceuticals Inc. accounts for about 0.008% of the 104,423-notice archive on 8 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

X-Gen Pharmaceuticals Inc.'s standing among 14,151 recalling firms

X-Gen Pharmaceuticals Inc. ranks 1,853rd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

X-Gen Pharmaceuticals Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

8 1853rd of 14151 higher than 12,296 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

X-Gen Pharmaceuticals Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows X-Gen Pharmaceuticals Inc. holds about 0.008% of archive notices alongside 8 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Apr 10, 2024

Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, After Reconstitution: For direct intravenous injection or must be further diluted before intravenous infusion, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc., Big Flats, NY 14814, NDC # 39822-0255-01.
FDA Drug Low Apr 10, 2024

Cyclophosphamide for Injection, USP, 500mg/vial, Lyophilized, Cytotoxic Agent, Single Dose Vial for Intravenous Use, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc. Big Flats, NY 14814, NDC # 39822-0250-01.
FDA Drug Moderate Apr 14, 2021

Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets, Manufactured for: X-GEN Phamaceuticals, Inc. Big Flats, NY 14814. NDC 39822-0310-5
FDA Drug Low Nov 27, 2019

Levetiracetam Injection, 500 mg/5mL, 10 single-use 5 mL vials, Rx only, Manufactured by: Agile Specialties Private Limited Pilot No. 14, Sipcot II, Hosur-635 109 Tamil Nadu, India, Manufactured for: X-Gen Pharmaceuticals, Inc. Big Flats, NY 14814, NDC 39822-4000-1
FDA Drug Low Apr 17, 2019

Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals, Big Flats, NY 14814, NDC 39822-2000-1.
FDA Drug Moderate Aug 16, 2017

Nystatin Topical Powder, USP, 100,000 USP units per gram, 15 grams per bottle, Rx only, Vensun, NDC 42543-052-61
FDA Drug Critical Apr 12, 2017

Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Single-Dose Vials per carton (NDC 39822-1030-2); Rx only, Distributed by: X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645.
FDA Drug Low Jul 30, 2014

Clonidine HCl Injection, 1000 mcg/10 mL (100 mcg/mL),10 mL Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals Inc., Big Flats, NY 14814, NDC 39822-2000-1.

X-Gen Pharmaceuticals Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (8 here).

Ab Sciex 8 Acumedia Manufacturers, Inc. 8 Adept Medical Ltd 8 Aju Pharm Co., Ltd. 8 Ambriola Co., Inc., The 8

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

American Regent, Inc. 8 Burel Pharmaceuticals Inc 8 Daiichi Sankyo Pharma Development 8 Drug Depot, Inc., dba Aps Pharmacy 8

Frequently Asked Questions

How many federal recall notices name X-Gen Pharmaceuticals Inc.? ▼
PlainRecalls indexes 8 distinct federal recall events naming X-Gen Pharmaceuticals Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does X-Gen Pharmaceuticals Inc. sit among other recalling firms? ▼
X-Gen Pharmaceuticals Inc. ranks #1,853 of 14,151 by distinct recall-event count among 14,151 firms in this archive (87th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of X-Gen Pharmaceuticals Inc.'s notices? ▼
FDA Drug accounts for 8 of this firm's 8 indexed notices.
What product category dominates X-Gen Pharmaceuticals Inc.'s filing book? ▼
Filings for X-Gen Pharmaceuticals Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
X-Gen Pharmaceuticals Inc.: 8 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming X-Gen Pharmaceuticals Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026